SAN FRANCISCO -- Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free survival (PFS) in patients with unresectable hepatocellular ...

First-line transarterial chemoembolization combined with radiotherapy is associated with improved survival among patients ...

Transarterial chemoembolization (TACE) is a type of treatment for liver cancer. It works by delivering chemotherapy drugs directly to the tumor and blocking its blood supply. Liver cancer occurs when ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Combining ...

The efficacy of transarterial techniques can be assessed in terms of imaging response (CT scan), biologic response (AFP), degree of tumor necrosis, patient survival or quality of life. The most ...

Prion and Alzheimer's disease are neurodegenerative disorders characterized by the accumulation of plaques containing misfolded PrP Sc and Aβ, respectively 1,2. Neurotoxic and aggregation-prone Aβ ...

Transcatheter arterial chemoembolization alone and with microwave ablation yielded comparable overall survival rates in patients with recurrent small hepatocellular carcinoma after resection, per ...

Please provide your email address to receive an email when new articles are posted on . Hepatocellular carcinoma, the sixth most common cancer, accounts for 90% of primary liver cancers worldwide. Its ...

One expert said the results have the potential to change the standard of care for some patients with the most common type of liver cancer. Adding durvalumab and bevacizumab to a well-known therapeutic ...

Combining TACE and SBRT offers a promising treatment for large HCC tumors, addressing TACE's limitations in intermediate-stage cases. Technological advancements have improved SBRT's precision and ...